Derriford Research Facility
Plymouth University is building a prestigious £17 million facility to provide a research-intensive environment to investigate cancer; infection, immunity and inflammation; & neurodegenerative diseases, including:
Brain tumours, dementia, Parkinson’s, Huntington’s, antibiotic resistance, oral cancer, non-Hodgkins lymphoma, Ebola and bovine tuberculosis.
Thousands affected by devastating diseases
So many diseases are without a cure, such as brain tumours, dementia, and Parkinson’s disease.
Currently, there are 850,000 people with dementia in the UK, and around 127,000 people living with Parkinson's with another person is diagnosed every hour. Brain tumours are the biggest cancer killer of children and the under-40 with brain cancer deaths rising; unlike other forms of cancers.
Plymouth University has a growing body of world-leading scientists undertaking cutting-edge research in health and medicine. However, their current dispersion across three sites impacts their collaborative efficiency and access to equipment.
Accelerating research towards a cure
With our research teams moving in in September 2017, the £17m Derriford Research Facility (DRF) provides a new space and hi-tech equipment to accelerate our world-leading research ever-closer to finding treatments, cures, and vaccines against some of the biggest health issues faced today.
The facility is purposefully placed between our existing Plymouth University Peninsula Schools of Medicine and Dentistry, and Derriford Hospital to create powerful collaborations between our research teams, clinicians, and the pharmaceutical and biotech industries to push discoveries through our 'bench to bedside and back' strategy.
Watch our video about the Derriford Research Facility
Building on our strengths
With leading expertise from around the globe we've made significant headway in many areas of research.
In the UK and we're ranked 1st in the UK for Research Output in Clinical Medicine by the Research Excellence Framework and we are in partnership with the charity Brain Tumour Research, and house a Brain Tumour Research Centre of Excellence.
The DRF will build on these strengths with the potential to attract more of the greatest minds in medicine to Plymouth. Our collaborations and networks will be far reaching and draw the attention of prominent commercial partners to fast-track our research into clinical trials.
We need your support
Building this DRF demonstrates our commitment to growing world-leading research.
We need your help to raise £1.5 million to grow our teams with PhD studentships, and to purchase vital equipment to push our pioneering research forward.
A key factor is the provision of modern state of the art facilities. Unfortunately, most grants, even from prestigious national bodies, do not cover these critical areas. Although Plymouth is a ‘young’ medical school and our teams are doing outstanding work with what they already have, we desperately need to expand that infrastructure if they are to thrive.
Press office news
- Deep-sea sponges – home to the next generation of antimicrobials? 17 August 2017
- Funding for gene therapy to injured peripheral nerves 9 August 2017
- University spin-out company addresses new vaccines 8 August 2017
- The escalating cost of alcohol misuse, obesity and viral hepatitis 4 August 2017
- National neurodegeneration role for Plymouth academic and clinician 14 July 2017